Farrukh Awan, MD, discusses the utilization of acalabrutinib in patients with chronic lymphocytic leukemia.
Amit G. Singal, MD, discusses the importance of early diagnosis for patients with hepatocellular carcinoma.
Yujin Hoshida, MD, PhD, discusses molecular subtyping in hepatocellular carcinoma.
Praveen Ramakrishnan, MD, assistant professor, Department of Internal Medicine, UT Southwestern Medical Center, discusses updates in diffuse large B-cell lymphoma (DLBCL) that were presented at the 2019 ASH Annual Meeting.
Madhuri Vusirikala, MD, discusses the benefit of hyper-CVAD and ponatinib in patients with Philadelphia chromosome–positive ALL.
Prapti Patel, MD, discusses the role of gilteritinib in patients with FLT3-mutated acute myeloid leukemia.
Farrukh Awan, MD, discusses the need for time-limited treatments in patients with chronic lymphocytic leukemia.
Ankit Kansagra, MD, discusses remaining questions with CAR T-cell therapy in multiple myeloma.